Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Indaptus Therapeutics Inc
INDP
Healthcare
Biotechnology
Indaptus Therapeutics, Inc., a clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human...
immunodeficiency virus infection, as well as for the treatment of advanced solid tumors. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:INDP)
New Post
View:
Posts & Comments
Threaded Posts
(235)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Oct 07, 2025 8:43am
Using technical analysis for this stock.
It is starting a new uptrend for shareholders today anyway,so good luck to all of you guys
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 26, 2025 3:38pm
INDP....Toast....cashless exercise of warrants
No position
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 26, 2025 2:27pm
INDP....all the volume started about 3 hrs after the open ..
I tend to think that this could get over $5 again No position...just watching
(476)
•••
Iseneschal
X
Comment by
Iseneschal
on Sep 26, 2025 2:25pm
RE:INDP..... What a Price swing today
There's less than 1 million shares o/s on this....I'd say the P.O was shorted by u know who....and now it's getting covered Something like that No Position
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 26, 2025 2:12pm
INDP..... What a Price swing today
P.O set up No position
(1)
•••
dragonfly454
X
Comment by
dragonfly454
on Mar 29, 2025 3:51pm
RE:Indaptus Therapeutics to Present at Two Upcoming Investor Co
yep
(1)
•••
dragonfly454
X
Post by
dragonfly454
on Mar 29, 2025 3:32pm
INDP'''it would be ironic
when the pumpers and dumpers who manipulated this have FOMO Combine the info below with the in vivo pre clinical where xenografts and mice were used already with BeiGene's tislelizumab and
...more
(1)
•••
dragonfly454
X
Post by
dragonfly454
on Mar 28, 2025 8:29pm
INDP
may be a once in a lifetime stock...@Clouder
(10)
•••
MikeTester
X
Post by
MikeTester
on Aug 02, 2024 7:43am
Indaptus Therapeutics, Inc. (NASDAQ:INDP): A Promising Immun
https://beyondspx.com/2024/08/01/indaptus-therapeutics-inc-nasdaqindp-a-promising-immunotherapy-pipeline-backed-by-solid-financials/
(9)
•••
MoMoneyNow
X
Post by
MoMoneyNow
on Oct 22, 2021 12:54pm
A shorters wet dream paradise
A real POFS!!
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Lode Gold Enters into Exclusive LOI with a Mining Company to Advance Fremont Gold Project
Mt Todd has emerged as one of the most compelling undeveloped gold assets globally
Environmental technology company enters a new strategic phase focused on scale and profitability